TRCNF (Transnational Cannabis) Cyclically Adjusted Revenue per Share: $0.00 (As of Nov. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Transnational Cannabis Cyclically Adjusted Revenue per Share?

Transnational Cannabis TRCNF -97.50% Cyclically Adjusted Revenue per Share is $0.00 as of Nov. 2019.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Transnational Cannabis's adjusted revenue per share for the three months ended in Nov. 2019 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Nov. 2019.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-18), Transnational Cannabis's current stock price is $4.0E-5. Transnational Cannabis's Cyclically Adjusted Revenue per Share for the quarter that ended in Nov. 2019 was $0.00. Transnational Cannabis's Cyclically Adjusted PS Ratio of today is .


Transnational Cannabis  (OTCPK:TRCNF) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Transnational Cannabis Cyclically Adjusted Revenue per Share Related Terms


Transnational Cannabis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Transnational Cannabis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transnational Cannabis Cyclically Adjusted Revenue per Share Chart

Transnational Cannabis Annual Data
Trend Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Transnational Cannabis Quarterly Data
Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TRCNF vs CLSH, KAYS, ACUR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Transnational Cannabis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transnational Cannabis Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Transnational Cannabis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Transnational Cannabis's Cyclically Adjusted PS Ratio falls into.



Transnational Cannabis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Transnational Cannabis's adjusted Revenue per Share data for the three months ended in Nov. 2019 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Nov. 2019 (Change)*Current CPI (Nov. 2019)
=0/107.7693*107.7693
=0.000

Current CPI (Nov. 2019) = 107.7693.

Transnational Cannabis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201002 0.000 91.335 0.000
201005 0.000 91.888 0.000
201008 0.000 92.204 0.000
201011 0.000 92.836 0.000
201102 0.000 93.311 0.000
201105 0.000 95.286 0.000
201108 0.000 95.049 0.000
201111 0.000 95.523 0.000
201202 0.000 95.760 0.000
201205 0.000 96.471 0.000
201208 0.000 96.234 0.000
201211 0.000 96.313 0.000
201302 0.000 96.945 0.000
201305 0.000 97.182 0.000
201308 0.000 97.261 0.000
201311 0.000 97.182 0.000
201402 0.000 98.051 0.000
201405 0.000 99.394 0.000
201408 0.000 99.315 0.000
201411 0.000 99.078 0.000
201502 0.000 99.078 0.000
201505 0.000 100.263 0.000
201508 0.000 100.579 0.000
201511 0.002 100.421 0.002
201602 0.000 100.421 0.000
201605 0.000 101.765 0.000
201608 0.000 101.686 0.000
201611 0.000 101.607 0.000
201702 0.000 102.476 0.000
201705 0.000 103.108 0.000
201708 0.000 103.108 0.000
201711 0.000 103.740 0.000
201802 0.000 104.688 0.000
201805 0.000 105.399 0.000
201808 0.000 106.031 0.000
201811 0.000 105.478 0.000
201902 0.000 106.268 0.000
201905 0.000 107.927 0.000
201908 0.000 108.085 0.000
201911 0.000 107.769 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
Transnational Cannabis (TRCNF) has a Cyclically Adjusted Revenue per Share of $0.00 as of Nov. 2019. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Transnational Cannabis and its competitors.
Is Transnational Cannabis' Cyclically Adjusted Revenue per Share too high?
Transnational Cannabis' current Cyclically Adjusted Revenue per Share is $0.00.
How does Transnational Cannabis' Cyclically Adjusted Revenue per Share compare to CLSH and KAYS?
Transnational Cannabis' Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Transnational Cannabis and its competitors. Transnational Cannabis's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transnational Cannabis stock overvalued right now?
Transnational Cannabis (TRCNF) has a current Cyclically Adjusted Revenue per Share of $0.00. The current Cyclically Adjusted Revenue per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Transnational Cannabis (TRCNF), the current Cyclically Adjusted Revenue per Share is $0.00 as of Nov. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Transnational Cannabis Business Description

Address 37 King Street East, Suite 409, Toronto, ON, CAN, M5C 1E9
Transnational Cannabis Ltd, formerly ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa, and Denmark.